Entity Common Stock, Shares Outstanding of IVERIC bio, Inc. from Q3 2013 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IVERIC bio, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2013 to Q1 2023.
  • IVERIC bio, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 01 May 2023 was 137,782,748, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IVERIC bio, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 137,782,748 +21,363,514 +18% 01 May 2023 10-Q 10 May 2023 2023 Q1
Q3 2022 120,722,802 +6,081,523 +5.3% 31 Oct 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 118,077,814 +14,068,416 +14% 22 Jul 2022 10-Q 26 Jul 2022 2022 Q2
Q1 2022 116,419,234 +26,164,118 +29% 02 May 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 114,641,279 +25,073,735 +28% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 104,009,398 +14,507,175 +16% 30 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 90,255,116 +39,999,218 +80% 30 Apr 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 89,567,544 +47,961,355 +115% 02 Nov 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 89,502,223 +47,939,528 +115% 03 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 50,255,898 +8,834,350 +21% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 41,606,189 +339,518 +0.82% 08 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 41,562,695 +5,364,259 +15% 29 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 41,421,548 +5,270,216 +15% 25 Feb 2019 10-K 28 Feb 2019 2018 FY
Q3 2018 41,266,671 +5,227,988 +15% 31 Oct 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 36,198,436 +255,557 +0.71% 31 Jul 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 36,151,332 +298,505 +0.83% 27 Feb 2018 10-K 05 Mar 2018 2017 FY
Q3 2017 36,038,683 +340,987 +0.96% 06 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 35,942,879 +349,703 +0.98% 28 Jul 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 35,852,827 +482,146 +1.4% 28 Apr 2017 10-Q 03 May 2017 2017 Q1
Q3 2016 35,697,696 +738,123 +2.1% 04 Nov 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 35,593,176 +851,409 +2.5% 01 Aug 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 35,370,681 +1,072,445 +3.1% 02 May 2016 10-Q 09 May 2016 2016 Q1
Q3 2015 34,959,573 +1,308,385 +3.9% 30 Oct 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 34,741,767 +1,255,189 +3.7% 31 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 34,298,236 +979,661 +2.9% 01 May 2015 10-Q/A 28 Jul 2015 2015 Q1
Q3 2014 33,651,188 +2,277,699 +7.3% 05 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 33,486,578 31 Jul 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 33,318,575 28 Feb 2014 10-K 11 Mar 2014 2013 FY
Q3 2013 31,373,489 08 Nov 2013 10-Q 13 Nov 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.